Results 81 to 90 of about 287,217 (298)
A CRISPR‐free mitochondrial RNA m1A demethylation (MRD) editor combining MTS, PUF proteins, and ALKBH3 enables precise m1A removal from mitochondrial mRNA and tRNA, which influences mitochondrial protein levels, cellular proliferation, ATP production, and mitochondrial respiration. Subsequently, in vivo demethylation of the m1A modification is achieved
Xiangrui Li +13 more
wiley +1 more source
Follow-up Study of a Child with Severe Combined Immune Deficiency
We present the results of 7-year follow-up of a patient with primary immunodeficiency, such as severe combined immune deficiency, X-linked variant. The child has been ill from 11 month of age.
T. B. Pavlova, V. M. Shinkareva
doaj +1 more source
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions
C. Dvorak +50 more
semanticscholar +1 more source
In the US, the assay of T cell receptor excision circles (TRECs) in newborn dried blood spot specimens to detect severe combined immunodeficiency (SCID) was first piloted in 2008 in the state of Wisconsin.
M. Dorsey, J. Puck
semanticscholar +1 more source
Severe Combined Immunodeficiency due to NHEJ1 Deficiency [PDF]
National Cancer Institute
openalex +1 more source
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1
This study identifies transmembrane protein adipocyte‐associated 1 (TPRA1) as a novel receptor for oncolytic virus M1 (OVM). TPRA1's ectodomain binds OVM particles, while its intracellular domain facilitates virus internalization, promoting efficient viral entry.
Linyi Hu +20 more
wiley +1 more source
Approach to the child with recurrent infections
Children with a history of recurrent, severe, or unusual infections present a diagnostic challenge. It is important to maintain a high index of suspicion for the diagnosis of immunodeficiency, for early diagnosis and treatment can improve outcome ...
Suzan A AlKhater
doaj
Newborn screening for severe combined immunodeficiency: a primer for clinicians
KEY POINTS Severe combined immunodeficiency is caused by genetic defects that profoundly impair development of the immune system.[1][1],[2][2] The condition is fatal early in life if affected infants do not receive therapy to restore immune function in ...
C. Biggs +4 more
semanticscholar +1 more source
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He +17 more
wiley +1 more source

